Đang chuẩn bị liên kết để tải về tài liệu:
Total serum N‑glycans associate with response to immune checkpoint inhibition therapy and survival in patients with advanced melanoma
Đang chuẩn bị nút TẢI XUỐNG, xin hãy chờ
Tải xuống
Immune checkpoint inhibitors (ICIs) have revolutionized the treatment of melanoma and other cancers. However, no reliable biomarker of survival or response has entered the clinic to identify those patients with melanoma who are most likely to benefit from ICIs. Glycosylation affects proteins and lipids’ structure and functions. |